Articoli con mandati relativi all'accesso pubblico - Daniel J Müller (Mueller)Ulteriori informazioni
Non disponibili pubblicamente: 69
Polymorphisms of the HTR2C Gene and Antipsychotic-Induced Weight Gain: An Update and Meta-Analysis
MN Sicard, CC Zai, AK Tiwari, RP Souza, HY Meltzer, JA Lieberman, ...
Pharmacogenomics 11 (11), 1561-1571, 2010
Mandati: Canadian Institutes of Health Research
Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel
C Bousman, A Al Maruf, DJ Müller
Current opinion in psychiatry 32 (1), 7-15, 2019
Mandati: US National Institutes of Health, Canadian Institutes of Health Research
Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed
TA Shams, DJ Müller
Current psychiatry reports 16, 1-8, 2014
Mandati: Canadian Institutes of Health Research
Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain
DJ Müller, CC Zai, M Sicard, E Remington, RP Souza, AK Tiwari, ...
The Pharmacogenomics Journal 12 (2), 156-164, 2010
Mandati: US National Institutes of Health, Canadian Institutes of Health Research
The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain
S Kanji, TM Fonseka, VS Marshe, V Sriretnakumar, MK Hahn, DJ Müller
European archives of psychiatry and clinical neuroscience 268, 3-15, 2018
Mandati: Canadian Institutes of Health Research
GWAS-based machine learning approach to predict duloxetine response in major depressive disorder
M Maciukiewicz, VS Marshe, AC Hauschild, JA Foster, S Rotzinger, ...
Journal of psychiatric research 99, 62-68, 2018
Mandati: Canadian Institutes of Health Research
The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain
GCM Zai, CCH Zai, NI Chowdhury, AK Tiwari, RP Souza, JA Lieberman, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 39 (1), 96-101, 2012
Mandati: Canadian Institutes of Health Research
Disturbed frontal gyrification within families affected with schizophrenia
P Falkai, WG Honer, T Kamer, S Dustert, K Vogeley, T Schneider-Axmann, ...
Journal of Psychiatric Research 41 (10), 805-813, 2007
Mandati: German Research Foundation
Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysis
M Sajjadian, RW Lam, R Milev, S Rotzinger, BN Frey, CN Soares, ...
Psychological Medicine 51 (16), 2742-2751, 2021
Mandati: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder
EJ Brandl, AK Tiwari, X Zhou, J Deluce, JL Kennedy, DJ Müller, ...
The pharmacogenomics journal 14 (2), 176-181, 2014
Mandati: Canadian Institutes of Health Research
Symptomatic and functional outcomes and early prediction of response to escitalopram monotherapy and sequential adjunctive aripiprazole therapy in patients with major …
SH Kennedy, RW Lam, S Rotzinger, RV Milev, P Blier, J Downar, ...
The Journal of Clinical Psychiatry 80 (2), 2236, 2019
Mandati: Canadian Institutes of Health Research
Physicians' opinions following pharmacogenetic testing for psychotropic medication
LM Walden, EJ Brandl, A Changasi, JE Sturgess, A Soibel, JFD Notario, ...
Psychiatry Research 229 (3), 913-918, 2015
Mandati: Canadian Institutes of Health Research
Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia
CC Zai, AK Tiwari, M Mazzoco, V de Luca, DJ Müller, SA Shaikh, ...
Journal of psychiatric research 47 (11), 1760-1765, 2013
Mandati: Canadian Institutes of Health Research
ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype
TAP Lett, CC Zai, AK Tiwari, SA Shaikh, O Likhodi, JL Kennedy, DJ Müller
The World Journal of Biological Psychiatry 12 (5), 392-397, 2011
Mandati: Canadian Institutes of Health Research
Pharmacogenetics of tardive dyskinesia: an updated review of the literature
RK Lanning, CC Zai, DJ Müller
Pharmacogenomics 17 (12), 1339-1351, 2016
Mandati: Canadian Institutes of Health Research
Novel genetic variants in carboxylesterase 1 predict severe early‐onset capecitabine‐related toxicity
S Hamzic, D Kummer, S Milesi, D Mueller, M Joerger, S Aebi, U Amstutz, ...
Clinical Pharmacology & Therapeutics 102 (5), 796-804, 2017
Mandati: Swiss National Science Foundation
Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update
V Sriretnakumar, E Huang, DJ Müller
Expert opinion on drug metabolism & toxicology 11 (11), 1709-1731, 2015
Mandati: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Pharmacogenetics of obsessive–compulsive disorders
EJ Brandl, DJ Müller, MA Richter
Pharmacogenomics 13 (1), 71-81, 2012
Mandati: Canadian Institutes of Health Research
The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: a pilot study
A Baskaran, F Farzan, R Milev, CA Brenner, S Alturi, MP McAndrews, ...
Journal of affective disorders 227, 542-549, 2018
Mandati: Canadian Institutes of Health Research
Association between the DAOA/G72 gene and bipolar disorder and meta‐analyses in bipolar disorder and schizophrenia
DJ Müller, CC Zai, T Shinkai, J Strauss, JL Kennedy
Bipolar disorders 13 (2), 198-207, 2011
Mandati: Canadian Institutes of Health Research
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software